文献速递心脑血管急症重症综合管理与镇静镇痛

输血策略对心肌梗死合并贫血患者生活质量的影响:MINT随机临床试验的二次分析

Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia: A Secondary Analysis of the MINT Randomized Clinical Trial.
PubMed 文献 · JAMA Intern Med · 2025-01-01
一句话结论MINT试验二次分析显示,对心肌梗死合并贫血患者,宽松与限制性输血策略在30天生活质量上无差异。

该研究为MINT随机临床试验的预设二次分析,纳入144个中心、6个国家、2844例急性心肌梗死合并贫血(血红蛋白<10 g/dL)住院成人,比较限制性(血红蛋白7-8 g/dL)与宽松(血红蛋白<10 g/dL)红细胞输血策略对30天EQ-5D-5L生活质量的影响。结果显示,两种策略在30天时任何EQ-5D-5L生活质量评分(均值或中位数)均无差异;尽管宽松组在日常活动、活动能力和自我照顾领域报告无问题的比例略高,但均无统计学显著性。调整混合效应线性回归显示输血策略与任何生活质量结局均无关联。预设亚组分析中,仅有心力衰竭史患者显示宽松策略与更好生活质量评分相关(健康今日评分:β,2.06 [95% CI,-0.23至4.35] vs -1.44 [95% CI,-3.81至0.92];P=0.04)。

要点

  • 在心肌梗死合并贫血患者中,宽松输血策略(血红蛋白<10 g/dL)与限制性策略(血红蛋白7-8 g/dL)相比,30天EQ-5D-5L生活质量评分无差异。
  • 宽松组 vs 限制性组在日常活动领域报告无问题的比例分别为39.9%(506/1268) vs 37.9%(473/1247),差异无统计学显著性。
  • 宽松组 vs 限制性组在活动能力领域报告无问题的比例分别为37.3%(474/1270) vs 36.7%(460/1254),差异无统计学显著性。
  • 宽松组 vs 限制性组在自我照顾领域报告无问题的比例分别为67.5%(858/1271) vs 64.0%(803/1254),差异无统计学显著性。
  • 仅在有心力衰竭史的患者中,宽松输血策略与更好健康今日评分相关(β,2.06 [95% CI,-0.23至4.35] vs -1.44 [95% CI,-3.81至0.92];P=0.04)。

适用人群与场景

  • 急性心肌梗死合并贫血(血红蛋白<10 g/dL)的住院成人。
  • 来自144个中心、6个国家的参与者。
  • 纳入有生活质量数据收集的患者以及30天随访前死亡的患者。

诊断标准与关键阈值

  • 贫血定义:血红蛋白<10 g/dL。
  • 限制性输血策略:血红蛋白7至8 g/dL。
  • 宽松输血策略:血红蛋白<10 g/dL。

处置流程与药物剂量

  • 限制性红细胞输血策略:血红蛋白阈值7至8 g/dL。
  • 宽松红细胞输血策略:血红蛋白阈值<10 g/dL。

研究设计与关键结果

  • 研究类型:MINT随机临床试验的预设二次分析,比较宽松 vs 限制性红细胞输血策略。
  • 样本量:MINT试验随机3504例,本分析纳入2844例;其中2525例(88.8%;限制性组1254例[49.7%],宽松组1271例[50.3%])有生活质量数据,319例(11.2%)在30天随访前死亡。
  • 人群特征:1551例(54.5%)为男性,平均(SD)年龄71.9(11.5)岁。
  • 主要终点结果:30天时,两种输血策略在任何EQ-5D-5L生活质量结局的均值或中位数评分上均无差异。
  • 关键次要终点:宽松组 vs 限制性组在日常活动领域报告无问题(相比任何问题)的比例分别为39.9%(506/1268) vs 37.9%(473/1247),活动能力领域分别为37.3%(474/1270) vs 36.7%(460/1254),自我照顾领域分别为67.5%(858/1271) vs 64.0%(803/1254),均无统计学显著性。
  • 调整混合效应线性回归显示,指定输血策略与任何生活质量结局的均值差异均无关联。
  • 预设亚组分析:在有心力衰竭史的患者中,宽松输血策略与更好健康今日评分相关(β,2.06 [95% CI,-0.23至4.35] vs -1.44 [95% CI,-3.81至0.92];P=0.04)。

证据类型、等级与局限

  • 证据类型:随机临床试验的预设二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于心肌梗死合并贫血患者,宽松输血策略(血红蛋白<10 g/dL)与限制性策略(血红蛋白7-8 g/dL)相比未改善30天生活质量,支持在整体人群中不因生活质量考虑而采用更高血红蛋白阈值输血。
  • 有心力衰竭史的患者可能从宽松输血策略中获得生活质量获益(健康今日评分β,2.06 [95% CI,-0.23至4.35] vs -1.44 [95% CI,-3.81至0.92];P=0.04),但作者认为需额外研究进一步验证输血对心肌梗死合并心力衰竭患者生活质量的影响。

指南或共识出处

  • MINT(Myocardial Ischemia and Transfusion)随机临床试验,ClinicalTrials.gov标识符NCT02981407。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Both myocardial infarction (MI) and anemia have deleterious effects on health-related quality of life (QOL). Red blood cell (RBC) transfusion may improve QOL after MI by relieving symptoms and/or increasing functional capacity.

OBJECTIVE: To evaluate whether a liberal transfusion strategy compared with a more restrictive transfusion strategy affects QOL in patients with MI and anemia.

DESIGN, SETTING, AND PARTICIPANTS: This analysis of QOL as a prespecified secondary outcome of the Myocardial Ischemia and Transfusion (MINT) trial, a randomized clinical trial comparing a liberal vs restrictive RBC transfusion strategy, included participants from 144 sites across 6 countries. Hospitalized adults with acute MI and anemia (hemoglobin [Hb] less than 10 g/dL). The MINT trial randomized 3504 patients, and this analysis included those who had QOL data collected and those who died before the 30-day follow-up period. Data were collected from April 2017 to April 2023, and data were analyzed from February 2024 to January 2025.

INTERVENTIONS: The MINT trial randomized patients to a restrictive (Hb of 7 to 8 g/dL) or a liberal (Hb of less than 10 g/dL) RBC transfusion strategy.

MAIN OUTCOMES AND MEASURES: QOL was measured using the EQ-5D-5L 30 days after randomization.

RESULTS: Of 2844 included patients, 1551 (54.5%) were male, and the mean (SD) age was 71.9 (11.5) years. A total of 2525 (88.8%; 1254 [49.7%] in the restrictive group and 1271 [50.3%] in the liberal group) had QOL data, and 319 (11.2%) died before 30-day follow-up. Overall, there were no differences in mean or median scores for any EQ-5D-5L QOL outcome between assigned transfusion strategies at 30 days postrandomization. Although a higher percentage of patients in the liberal compared with the restrictive transfusion group reported no problems compared with any problem in usual activities (506 of 1268 [39.9%] vs 473 of 1247 [37.9%]), mobility (474 of 1270 [37.3%] vs 460 of 1254 [36.7%]), and self-care (858 of 1271 [67.5%] vs 803 of 1254 [64.0%]) domains, none of these differences were statistically significant. Adjusted mixed-effects linear regressions showed no association between assigned transfusion strategy and mean differences in any QOL outcome. Adjusted regressions in several prespecified subgroups showed an association between a liberal transfusion strategy and better QOL scores in domains related to functional capacity, but the effects were only statistically significant in patients with a history of heart failure (Health Today rating: β, 2.06 [95% CI, -0.23 to 4.35] vs -1.44 [95% CI, -3.81 to 0.92]; P = .04).

CONCLUSIONS AND RELEVANCE: This secondary analysis of the MINT trial found that in patients with MI and anemia, a liberal transfusion strategy compared with a restrictive transfusion strategy did not affect QOL outcomes 30 days after randomization. This suggests that higher Hb levels maintained with RBC transfusion may not offer significant benefits to QOL overall in patients with MI and anemia. Additional studies may be useful for further examining and validating transfusion's effect on QOL in patients with MI and heart failure.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02981407.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Prochaska MT, Portela GT, Brooks MM, et al. Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia: A Secondary Analysis of the MINT Randomized Clinical Trial. JAMA Intern Med. 2025. PMID: 40459491. doi:10.1001/jamainternmed.2025.0654

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。